Germany approves first live human testing trial of potential COVID-19 vaccine
Germany's vaccines regulator approved live human testing of a potential vaccine against COVID-19 developed by German biotech company BioNTech, the...
Germany's vaccines regulator approved live human testing of a potential vaccine against COVID-19 developed by German biotech company BioNTech, the...
Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients...
Best practices in the pharma and biotech industries will take centre stage at the 17th Annual CPhI Pharma Awards, powered...
Sygnature Group is supporting the Government’s COVID-19 testing strategy with the loan of a key piece of equipment. The machine,...
Sanofi and GSK announce that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using...
As the COVID-19 pandemic continues globally, biopharma companies have rushed to develop vaccines, new drugs and repurpose old drugs in...
Almac Clinical Technologies, a member of the Almac Group, has announced the expedited deployment and support of multiple Interactive Response...
Regeneron Pharmaceuticals and Zai Lab announced a strategic collaboration for the development and commercialization of REGN1979 (CD20xCD3 bispecific antibody) in...
CROMSOURCE has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company. This trial...
Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians,...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.